Antiviral Drugs for Influenza
Date: January 13, 2020
Issue #:
1589Summary:
Influenza is generally a self-limited illness, but
pneumonia, respiratory failure, and death can occur.
FDA-approved antiviral drugs for influenza are listed
in Table 2. The neuraminidase inhibitors oseltamivir
(Tamiflu, and generics), which is taken orally, and
zanamivir(Relenza), which is inhaled, are approved
for prophylaxis and treatment of acute uncomplicated
influenza. The IV neuraminidase inhibitor peramivir(Rapivab) and the oral polymerase acidic (PA)
endonuclease inhibitor baloxavir marboxil(Xofluza)
are approved only for treatment. All of these drugs
are active against both influenza A and influenza B
viruses. Updated information on influenza activity
and antiviral resistance is available from the CDC atwww.cdc.gov/flu.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Antiviral drugs baloxavir marboxil FluMist influenza Influenza vaccine Oseltamivir Peramivir Rapivab Relenza Tamiflu Xofluza Zanamivir Source Type: research
More News: Drugs & Pharmacology | Influenza | Influenza Vaccine | Oseltamivir | Pneomococcal Vaccine | Pneumonia | Relenza | Respiratory Medicine | Tamiflu | Vaccines | Zanamivir